approval
savePAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalFeb 11, 2026 · 242d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalFeb 11, 2026 · 242d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalJan 31, 2025 · 618d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalNov 19, 2024 · 691d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalSep 12, 2024 · 759d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalMay 25, 2023 · 1235d ago
same company · ±60 days · 6
- approvallorlatinib: LORBRENA (LORLATINIB) — FDA approvalFeb 18, 2025
- approvaltofacitinib citrate ER: XELJANZ XR (TOFACITINIB CITRATE) — FDA approvalFeb 21, 2025
- approvaltofacitinib citrate ER: XELJANZ (TOFACITINIB CITRATE) — FDA approvalFeb 21, 2025
- approvalPAXLOVID (COPACKAGED): PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalJan 31, 2025
- approvalUNASYN: UNASYN (AMPICILLIN SODIUM) — FDA approvalJan 31, 2025
- approvaltaliglucerase alfa: ELELYSO (TALIGLUCERASE ALFA) — FDA approvalJan 17, 2025
comments(0)
5-min edit window · permanent after that